> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Panel to Review Intraocular Pressure Drug
- URL: https://www.fdaweb.com/fda-panel-to-review-intraocular-pressure-drug/
- Published: 2017-09-21T12:00:00.000Z
- Updated: 2026-09-14T22:51:49.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139684

*Federal Register* notice: FDA has announced a 10/13 meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee. Panel members will discuss the safety and efficacy of a Aerie Pharmaceuticals NDA for netarsudil ophthalmic solution 0.02%, indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.